2021 International Open Access Week is here!
Find out more about this year’s Open Access Week, themed ‘It matters how we open knowledge: building structural equity’.
[VIDEO] Involving the patient from protocol to publication in real-world evidence studies
Emma Bagshaw, Mark Larkin and Sam Llewellyn from Vitaccess and Fulvio Baggi, Director of The European Myasthenia Gravis Association discuss the lifecycle of creating collaborative digital patient registries and taking them through to the publications.
Integrating the patient voice into plain language summaries
A new guide provides practical advice on how to increase patient engagement and involvement at every stage of their development.
Will preprint articles replace publication in traditional peer-reviewed journals?
The suggestion that preprints could replace traditional journals has been debated. Dr Haseeb Irfanullah provides arguments against this view.
[PODCAST] Achieving greater equity, diversity, and inclusion through health literacy
Laurie Myers and Stacy Robison discuss the importance of health literacy in equity, diversity, and inclusion.
Improving diversity and inclusivity in scientific publishing: can ‘editormetrics’ help?
Learn how a dataset of nearly half a million researchers can be used to reduce bias and increase equity.
Is abstract peer review affected by institutional and geographical bias?
Research from higher-status institutions and countries is postulated to receive more favourable peer review. A recent article suggests this may not be the case.
What are the potential applications of social media and altmetrics in the pharmaceutical industry?
How can pharma unlock the potential of social media? A recent article from EMWA’s Medical Writing journal discusses potential applications.
ISMPP West 2021 – All Hands on Deck: Opportunities for Connectivity, Transparency, and Inclusivity
ISMPP West 2021 is a LIVE IN-PERSON meeting on October 21-22, 2021, in Irvine, CA, plus a VIRTUAL Encore Event on October 28, 2021! Register now!
WHO and ICMRA announce a joint statement on data transparency and integrity
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
[PODCAST] Successfully navigating the changing medical conference landscape: part 2
David Barrett continues a discussion with Rob Matheis on how medical congresses can deliver value and opportunities for everyone.
How can the healthcare industry embrace the rise of social media video content?
Creators of Industry Voice share tips on how to leverage video content to generate discussion among experts, engage viewers, and build brand value.
New CONSORT extension for trials using cohorts and routinely collected data: CONSORT-ROUTINE
Find out what’s in the new CONSORT-ROUTINE checklist for randomised controlled trials using cohorts and routinely collected data.
Why loss of confidence in previously published findings does not necessarily lead to self-correction of the scientific record
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
The ISMPP authorship algorithm: standardising the application of the ICMJE authorship criteria
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
[PODCAST] Successfully navigating the changing medical conference landscape: part 1
How are medical societies innovating in the face of a changing medical conference landscape? David Barrett (CEO of the American Society of Gene & Cell Therapy) spoke with Rob Matheis to explain.